A retrospective analysis of 500 ERCP procedures: outcomes, adverse events, and risk factors over two years

Yunus Halil Polat; Ahmet Yozgat

Makale detayları

A retrospective analysis of 500 ERCP procedures: outcomes, adverse events, and risk factors over two years

Yazarlar:

Yunus Halil Polat | Ahmet Yozgat

Yayıncı:

MediHealth Academy Yayıncılık

Ana Başlıklar:

Gastroenteroloji ve Hepatoloji

Dergi:

Journal of Medicine and Palliative Care Vol.5 Issue 6, pp.309-313

Belge Tipi:

Makale

Yayın Tarihi:

12/2024

Belge Dili:

İngilizce

Document ID (Org No.):

2001334640

pISSN:

2717-7505

Anahtar kelimeler:

Özet:

 Aims: Endoscopic retrograde cholangiopancreatography ERCP is a widely used procedure for both the diagnosis and management of biliary and pancreatic ductal diseases. While it has been largely replaced by non-invasive imaging techniques for diagnostic purposes, ERCP remains the gold standard for therapeutic interventions. This study aims to retrospectively analyze the outcomes, adverse events, and success rates of ERCP procedures performed on 500 patients over two years. Methods: A retrospective review of 500 ERCP procedures performed at a single center over 24 months was conducted. Patient demographics, indications for ERCP, procedural outcomes, and adverse event rates were collected and analyzed. Success rates for therapeutic interventions, as well as risk factors for post-procedural adverse events, were identified. Results: The study revealed that 448 89.6 of ERCP procedures were successful in achieving the primary therapeutic goal e.g., stone extraction, stent placement. Adverse events occurred in 93 18.6 of cases, with post-ERCP pancreatitis being the most common adverse event n: 73, 14.6. Risk factors associated with adverse events included previous cholecystectomy p0.001, difficult cannulation p0.001, and prolonged procedure time p:0.003. Conclusion: ERCP remains a highly effective treatment tool for treating biliary and pancreatic diseases, although it carries the risk of many adverse events. The identification of key risk factors may help to minimize the incidence of adverse events and improve patient outcomes. The data collected in this study provide valuable insight into the current practice of ERCP and the role it plays in modern gastroenterology.

 Aims: Endoscopic retrograde cholangiopancreatography ERCP is a widely used procedure for both the diagnosis and management of biliary and pancreatic ductal diseases. While it has been largely replaced by non-invasive imaging techniques for diagnostic purposes, ERCP remains the gold standard for therapeutic interventions. This study aims to retrospectively analyze the outcomes, adverse events, and success rates of ERCP procedures performed on 500 patients over two years. Methods: A retrospective review of 500 ERCP procedures performed at a single center over 24 months was conducted. Patient demographics, indications for ERCP, procedural outcomes, and adverse event rates were collected and analyzed. Success rates for therapeutic interventions, as well as risk factors for post-procedural adverse events, were identified. Results: The study revealed that 448 89.6 of ERCP procedures were successful in achieving the primary therapeutic goal e.g., stone extraction, stent placement. Adverse events occurred in 93 18.6 of cases, with post-ERCP pancreatitis being the most common adverse event n: 73, 14.6. Risk factors associated with adverse events included previous cholecystectomy p0.001, difficult cannulation p0.001, and prolonged procedure time p:0.003. Conclusion: ERCP remains a highly effective treatment tool for treating biliary and pancreatic diseases, although it carries the risk of many adverse events. The identification of key risk factors may help to minimize the incidence of adverse events and improve patient outcomes. The data collected in this study provide valuable insight into the current practice of ERCP and the role it plays in modern gastroenterology.

 Aims: Endoscopic retrograde cholangiopancreatography ERCP is a widely used procedure for both the diagnosis and management of biliary and pancreatic ductal diseases. While it has been largely replaced by non-invasive imaging techniques for diagnostic purposes, ERCP remains the gold standard for therapeutic interventions. This study aims to retrospectively analyze the outcomes, adverse events, and success rates of ERCP procedures performed on 500 patients over two years. Methods: A retrospective review of 500 ERCP procedures performed at a single center over 24 months was conducted. Patient demographics, indications for ERCP, procedural outcomes, and adverse event rates were collected and analyzed. Success rates for therapeutic interventions, as well as risk factors for post-procedural adverse events, were identified. Results: The study revealed that 448 89.6 of ERCP procedures were successful in achieving the primary therapeutic goal e.g., stone extraction, stent placement. Adverse events occurred in 93 18.6 of cases, with post-ERCP pancreatitis being the most common adverse event n: 73, 14.6. Risk factors associated with adverse events included previous cholecystectomy p0.001, difficult cannulation p0.001, and prolonged procedure time p:0.003. Conclusion: ERCP remains a highly effective treatment tool for treating biliary and pancreatic diseases, although it carries the risk of many adverse events. The identification of key risk factors may help to minimize the incidence of adverse events and improve patient outcomes. The data collected in this study provide valuable insight into the current practice of ERCP and the role it plays in modern gastroenterology.

 Amaç: Endoskopik Retrograd Kolanjiyopankreatografi ERCP, biliyer ve pankreatik duktal hastalıkların hem tanısı hem de tedavisi için yaygın olarak kullanılan bir prosedürdür. Tanı amaçlı olarak yerini büyük ölçüde non-invaziv görüntüleme tekniklerine bırakmış olsa da, ERCP terapötik girişimler için altın standart olmaya devam etmektedir. Bu çalışmanın amacı, iki yıl boyunca 500 hastaya uygulanan ERCP prosedürlerinin sonuçlarını, advers olaylarını ve başarı oranlarını retrospektif olarak analiz etmektir. Yöntemler: Tek bir merkezde 24 ay boyunca gerçekleştirilen 500 ERCP prosedürünün retrospektif bir incelemesi yapıldı. Hasta demografisi, ERCP endikasyonları, prosedür sonuçları ve advers olay oranları toplandı ve analiz edildi. Terapötik müdahaleler için başarı oranlarının yanı sıra işlem sonrası advers olaylar için risk faktörleri belirlendi. Sonuçlar: Çalışma, ERCP prosedürlerinin 448inin 89,6 birincil terapötik hedefe örn. taş çıkarma, stent yerleştirme ulaşmada başarılı olduğunu ortaya koydu. Olguların 93ünde 18,6 advers olay meydana gelmiş olup, ERCP sonrası pankreatit en yaygın advers olaydır n: 73, 14,6. Advers olaylarla ilişkili risk faktörleri arasında önceki kolesistektomi p0.001, zor kanülasyon p0.001 ve uzamış işlem süresi p:0.003 yer almıştır. Tartışma: ERCP, birçok advers olay riski taşımasına rağmen, biliyer ve pankreatik hastalıkların tedavisinde oldukça etkili bir tedavi aracı olmaya devam etmektedir. Temel risk faktörlerinin belirlenmesi, advers olayların görülme sıklığının en aza indirilmesine ve hasta sonuçlarının iyileştirilmesine yardımcı olabilir. Bu çalışmada toplanan veriler, ERCPnin mevcut uygulaması ve modern gastroenterolojide oynadığı rol hakkında değerli bilgiler sağlamaktadır.

Makale detayları

A retrospective analysis of 500 ERCP procedures: outcomes, adverse events, and risk factors over two years

Yazarlar:

Yunus Halil Polat | Ahmet Yozgat

Yayıncı:

MediHealth Academy Yayıncılık

Ana Başlıklar:

Gastroenteroloji ve Hepatoloji

Dergi:

Journal of Medicine and Palliative Care Vol.5 Issue 6, pp.309-313

Belge Tipi:

Makale

Yayın Tarihi:

12/2024

Belge Dili:

İngilizce

Document ID (Org No.):

2001334640

pISSN:

2717-7505

ERCP

biliary diseases

therapeutic endoscopy

post-ERCP pancreatitis

adverse event rates

retrospective studyERCP

biliyer hastalıklar

terapötik endoskopi

ERCP sonrası pankreatit

advers olay oranları

retrospektif çalışma.

Sayı

Makale detayları

Yazarlar: Yunus Halil Polat | Ahmet Yozgat

Yayıncı: MediHealth Academy Yayıncılık

Ana Başlıklar: Gastroenteroloji ve Hepatoloji

Dergi: Journal of Medicine and Palliative Care Vol.5 Issue 6, pp.309-313

Belge Tipi: Makale

Yayın Tarihi: 12/2024

Belge Dili: İngilizce

Document ID (Org No.): 2001334640

pISSN: 2717-7505

Sayı

Yazarlar:

Yunus Halil Polat | Ahmet Yozgat

Yayıncı:

MediHealth Academy Yayıncılık

Ana Başlıklar:

Gastroenteroloji ve Hepatoloji

Dergi:

Journal of Medicine and Palliative Care Vol.5 Issue 6, pp.309-313

Belge Tipi:

Makale

Yayın Tarihi:

12/2024

Belge Dili:

İngilizce

Document ID (Org No.):

2001334640

pISSN:

2717-7505